Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Evaluate Long- Term Safety and Efficacy of Luspatercept in Subjects with Transfusion Dependent Who Received the First Dose of Luspatercept After Its Introduction in the Clinical Practice

NCT06875219 is registered in ClinicalTrials.gov with Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia as lead sponsor.

NCT NCT06875219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06875219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Evaluate Long- Term Safety and Efficacy of Luspatercept in Subjects with Transfusion Dependent Who Received the First Dose of Luspatercept After Its Introduction in the Clinical Practice
Lead sponsor
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
Phase
Observational
Overall status
Active, not recruiting
Start date
April 30, 2023
Completion date
February 24, 2026
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia major